ExploreWatchlistsPricing
  1. JP-listed companies
  2. M3, Inc.
  3. Financials
  4. Cash and cash equivalents

M3, Inc. (2413)

Market cap
¥1.07T
P/E ratio
23.8x
M3 transforms healthcare through digital platforms, connecting doctors, patients, and medical institutions with services ranging from clinical trials to career support.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndCash and cash equivalents (Million JPY)YoY (%)
Mar 31, 2025134,933-9.84%
Mar 31, 2024149,661+26.49%
Mar 31, 2023118,319+13.49%
Mar 31, 2022104,253+16.95%
Mar 31, 202189,144+85.92%
Mar 31, 202047,948+74.12%
Mar 31, 201927,538+74.42%
Mar 31, 201815,788+5.78%
Mar 31, 201714,926-17.94%
Mar 31, 201618,190+9.84%
Mar 31, 201516,561

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat